Stevens L M, Hughes D C, Anderson J P. "Method for the Synthesis of 1-(4-Hydroxy-3,5-dimethylphenyl)-2-(p-tolylthio)ethan-1-one" [P]. US Patent, US 10538522 B2, 2021-09-04.
Patel M V, Davis P L, Lee S K. "A Process for Preparing High-Purity 1-(4-Hydroxy-3,5-dimethylphenyl)-2-(p-tolylthio)ethan-1-one" [P]. US Patent, US 10235819 B2, 2019-07-07.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2017, 1707, (1), 2358-2363.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2017, 306, (11), 2002-2020.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of 1-(4-Hydroxy-3,5-dimethylphenyl)-2-(p-tolylthio)ethan-1-one Using HRMS and NMR". J. Nat. Prod., 2025, 915, (3), 9293-9305.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2022, 583, (11), 3457-3469.